Settlement Crushes Profit; Credit Growth Solid But Guidance Caution Signals Headwinds

The quarter's headline numbers mask a paradox: reported profit collapsed 53%, yet the core business posted the strongest credit growth in several quarters at 17.4% and robust deposit mobilization at 13.8%. That gap between headline and organics is the entire story of Q1 FY27.

On July 1, Bank of Baroda finalized an out-of-court settlement of USD 600 million (~₹5,250 Cr) with NMC Health PLC in Abu Dhabi and UK courts. This trade-finance liability—stemming from a 2017–2019 payment default by NMC, later revealed as a £2 billion fraud—had been sub-judice for years. The bank recorded the full amount as an exceptional item in Q1, reducing reported PAT from an underlying ₹5,500 Cr to ₹1,572.6 Cr. Management framed it as "commercially prudent" and "allowing the bank to focus on sustainable growth," but the timing and lack of prior warning—the annual report had not flagged it—raised immediate questions on governance oversight.

What the settlement cost in profit is what it buys in closure: the international operations that generated this exposure have been reshaped since 2021 (governance, AML frameworks, CRO/CCO oversight tightened). The domestic book is insulated. But the governance gap—how such a large contingent liability was not pre-flagged to investors—remains the quarter's deeper discomfort.

The stock has been under pressure since the all-time high of ₹325.5, now down 25.47% at ₹242.6. Post-result (announced July 24), the sell-off accelerated: day-1 drop -0.99%, day-3 -1.26%, day-5 -1.56%. The fact that the initial move did not fade but deteriorated is the market's own reading that this quarter is worse-than-it-looks. The stock now trades below its SMA20 (₹246.15), SMA50 (₹261.24), and SMA200 (₹278.92)—a confirmed downtrend. RSI at 40.9 (neutral-to-weak) suggests room to fall before oversold signals.

Institutional positioning corroborates caution. FII ownership held steady at 9.69% (down just 15 bps from Q3's 9.84%), suggesting no aggressive dumping—but no buying either. DII added 20 bps to 19.01%, a modest defensive tilt, while promoters remained flat at 63.97%. This is not a vote of confidence; it's indifference with a slight domestic institutional hedge.

The honest read: The bull case overstates the quarter. Credit growth is real, but it's yielding revenue growth of only 6.8% YoY—a disconnect that reflects a low-margin, deposit-heavy business model. Management's tone was defensive on NMC (rightfully so, given governance gaps) and over-assertive on growth (highlighting YoY numbers while downplaying sequential deterioration). ROA miss, margin compression, fee income decline, and the ECL overhang make this a steady-state quarter at best, not a re-rating catalyst. The market's 25% drawdown has absorbed some pain, but more could be in store if Q2 disappoints on ROA or guidance. Verdict: Hold.

Not revenue growth (which doesn't translate to profit), not credit growth (which is real but margin-light). Track ROA. The bank needs to prove it can recover to >1% by Q2, sustain it through Q4, and hit 1%+ as a full-year average despite the ECL headwind. If it can't, the 1% threshold—the psychological floor for any large bank—is breached, and re-rating continues. As of now, Q1's 0.25% ROA and management's defensive tone suggest that threshold is at risk. Watch Q2 for clarity on margin recovery and deposit-cost relief; that's the inflection point.